Achieve Life Sciences to Present at H.C. Wainwright BIOCONNECT Virtual Conference
07 January 2022 - 12:30AM
Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage
pharmaceutical company committed to the global development and
commercialization of cytisinicline for smoking cessation and
nicotine addiction, today announced that John Bencich, Chief
Executive Officer, will give a presentation at the H.C. Wainwright
BIOCONNECT Virtual Conference. The conference is taking place
virtually from January 10 - 13, 2022. Details for access to the
presentation are as follows:
H.C. Wainwright BIOCONNECT Virtual
Conference:Date: January 10, 2022Time: 7:00 am ETInvestors
can register for the conference HERE.
Following the conference, a webcast replay of the presentation
will be available on the Investor section of the company’s website,
Achieve Life Sciences.
About Achieve and Cytisinicline Tobacco
use is currently the leading cause of preventable death that is
responsible for more than eight million deaths worldwide and nearly
half a million deaths in the United States annually.1,2 More than
87% of lung cancer deaths, 61% of all pulmonary disease deaths, and
32% of all deaths from coronary heart disease are attributable to
smoking and exposure to secondhand smoke.2 Achieve’s focus is to
address the global smoking health and nicotine addiction epidemic
through the development and commercialization of cytisinicline.
Cytisinicline is a plant-based alkaloid with a high binding
affinity to the nicotinic acetylcholine receptor. It is believed to
aid in smoking cessation by interacting with nicotine receptors in
the brain by reducing the severity of nicotine withdrawal symptoms
and by reducing the reward and satisfaction associated with
smoking.
Cytisinicline is an investigational product candidate being
developed for treatment of nicotine addiction and has not been
approved by the Food and Drug Administration for any indication in
the United States. For more information on cytisinicline and
Achieve, visit www.achievelifesciences.com.
Investor Relations ContactRich
Cockrellachv@cg.capital(404) 736-3838
Media ContactGlenn
SilverGlenn.Silver@Finnpartners.com(646) 871-8485
References 1 World Health Organization.
WHO Report on the Global Tobacco Epidemic, 2019. Geneva: World
Health Organization, 2017. 2 U.S. Department of Health and
Human Services. The Health Consequences of Smoking – 50 Years of
Progress. A Report of the Surgeon General, 2014.
Achieve Life Sciences (NASDAQ:ACHV)
Historical Stock Chart
From Mar 2024 to Apr 2024
Achieve Life Sciences (NASDAQ:ACHV)
Historical Stock Chart
From Apr 2023 to Apr 2024